Dr. Philipp Backhaus is giving a presentation entitled “A new theranostic target in prostate cancer: First results from prostatic acid phosphatase (ACP3) imaging with [⁶⁸Ga]Ga-OncoACP3-DOTA PET in prostate cancer patients and comparison to [¹⁸F]F-PSMA-1007” about the initial clinical experience with Philochem’s ACP3-targeted radioligand ⁶⁸Ga-OncoACP3. The presentation will be held during the Session SS23 Oncology Discovery and Translational on Monday 23^rd June 2025 at 12:45 pm.

Follow the link for more details